E. Poullot

Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis.

J. Deux, E. Teiger, L. Hittinger, 2022, Mayo Clinic proceedings.

Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study

E. Teiger, L. Hittinger, B. Funalot, 2023, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival

A. Amiot, J. Deux, E. Teiger, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis

A. Maarek, A. Moktefi, T. Damy, 2022, EJHaem.

[Cardiac amyloidosis: State of art in 2022].

T. Damy, P. Fanen, S. Oghina, 2022, La Revue de medecine interne.

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement

F. Lemonnier, E. Teiger, O. Agbulut, 2021, PloS one.

Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

P. Brousset, O. Burlet-Schiltz, H. Mal, 2022, Haematologica.

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

A. Amiot, J. Lefaucheur, E. Audureau, 2023, Frontiers in Cardiovascular Medicine.

Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis

R. Carter-Storch, M. Annabi, M. Kharoubi, 2024, Journal of the American Heart Association.

Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.

J. Deux, E. Audureau, E. Itti, 2021, Journal of the American College of Cardiology.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

M. Stegall, S. Knechtle, P. Grimbert, 2019, Journal of the American Society of Nephrology : JASN.

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis

J. Deux, J. Lefaucheur, F. Lemonnier, 2021, ESC heart failure.

Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis

J. Deux, J. Lefaucheur, E. Teiger, 2020, European journal of heart failure.